EDGAR Filing Documents for 0001193125-16-459785

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-16-459785

Filing Date

2016-02-11

Accepted

2016-02-11 16:44:19

Documents

112

Period of Report

2015-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	d120587d20f.htm	20-F	2895485
2	EX-8	d120587dex8.htm	EX-8	5200
3	EX-10	d120587dex10.htm	EX-10	2724
4	EX-12.(I)	d120587dex12i.htm	EX-12.(I)	6103
5	EX-12.(II)	d120587dex12ii.htm	EX-12.(II)	8588
6	EX-13	d120587dex13.htm	EX-13	4632
	Complete submission text file	0001193125-16-459785.txt		14722046

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	teva-20151231.xml	EX-101.INS	3280806
8	XBRL TAXONOMY EXTENSION SCHEMA	teva-20151231.xsd	EX-101.SCH	191536
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	teva-20151231_cal.xml	EX-101.CAL	163071
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	teva-20151231_def.xml	EX-101.DEF	611637
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	teva-20151231_lab.xml	EX-101.LAB	1154280
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	teva-20151231_pre.xml	EX-101.PRE	1099951

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131

Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)